India Non Invasive Prenatal Testing Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$85.0

Forecast, 2030 (US$M)

$242.4

CAGR, 2023 - 2030

14%

Report Coverage

India

India non invasive prenatal testing market, 2018-2030 (US$M)

Related Markets

Global Non Invasive Prenatal Testing Industry Outlook

North America Non Invasive Prenatal Testing Market Outlook

U.S. Non Invasive Prenatal Testing Market Outlook

Canada Non Invasive Prenatal Testing Market Outlook

Europe Non Invasive Prenatal Testing Market Outlook

Germany Non Invasive Prenatal Testing Market Outlook

France Non Invasive Prenatal Testing Market Outlook

Italy Non Invasive Prenatal Testing Market Outlook

Spain Non Invasive Prenatal Testing Market Outlook

Denmark Non Invasive Prenatal Testing Market Outlook

Sweden Non Invasive Prenatal Testing Market Outlook

Norway Non Invasive Prenatal Testing Market Outlook

UK Non Invasive Prenatal Testing Market Outlook

Asia Pacific Non Invasive Prenatal Testing Market Outlook

Japan Non Invasive Prenatal Testing Market Outlook

China Non Invasive Prenatal Testing Market Outlook

Australia Non Invasive Prenatal Testing Market Outlook

South Korea Non Invasive Prenatal Testing Market Outlook

Singapore Non Invasive Prenatal Testing Market Outlook

Thailand Non Invasive Prenatal Testing Market Outlook

Latin America Non Invasive Prenatal Testing Market Outlook

Mexico Non Invasive Prenatal Testing Market Outlook

Argentina Non Invasive Prenatal Testing Market Outlook

Brazil Non Invasive Prenatal Testing Market Outlook

MEA Non Invasive Prenatal Testing Market Outlook

South Africa Non Invasive Prenatal Testing Market Outlook

Saudi Arabia Non Invasive Prenatal Testing Market Outlook

UAE Non Invasive Prenatal Testing Market Outlook

Kuwait Non Invasive Prenatal Testing Market Outlook

India non invasive prenatal testing market highlights

The India non invasive prenatal testing market generated a revenue of USD 85.0 million in 2022 and is expected to reach USD 242.4 million by 2030.
The India market is expected to grow at a CAGR of 14% from 2023 to 2030.
In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.

Non invasive prenatal testing market data book summary

Market revenue in 2022	USD 85.0 million
Market revenue in 2030	USD 242.4 million
Growth rate	14% (CAGR from 2022 to 2030)
Largest segment	13-24 weeks
Fastest growing segment	0-12 weeks
Historical data	2018 - 2021
Base year	2022
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	0-12 weeks, 13-24 weeks, 25-36 weeks
Key market players worldwide	CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics

Other key industry trends

In terms of revenue, India accounted for 2.2% of the global non invasive prenatal testing market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China non invasive prenatal testing market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 242.4 million by 2030.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Non Invasive Prenatal Testing Market Scope

Non invasive prenatal testing market segmentation & scope

Gestation Period

0-12 weeks

13-24 weeks

25-36 weeks

Risk

High & Average Risk

Low Risk

Method

Ultrasound Detection

Biochemical Screening Tests

Cell-Free DNA in Maternal Plasma Tests

Technology

NGS

Array Technology

PCR

Others

Product

Consumables & Reagents

Instruments

Application

Trisomy

Microdeletion Syndrome

Other Applications

End Use

Hospitals & Clinics

Diagnostic Laboratories

Regions

Europe

Countries

Brazil

Mexico

Denmark

France

Italy

Norway

Spain

Sweden

Canada

U.S.

Saudi Arabia

South Africa

UAE

Australia

India

Japan

Singapore

South Korea

Thailand

Germany

Kuwait

China

Non Invasive Prenatal Testing Market Companies

Name	Profile	# Employees	HQ	Website

India non invasive prenatal testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.

13-24 weeks was the largest segment with a revenue share of 52% in 2022. Horizon Databook has segmented the India non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.

In India, NIPT is allowed to be utilized only to detect genetic disorders in embryos, such as sickle cell anemia, cystic fibrosis, phenylketonuria, and thalassemia. NIPT procedures are carried out only at registered genetic clinics and by a registered & qualified person under the Pre-Conception and Prenatal Diagnostic Due to the high prices of NIPT, doctors sent the samples abroad for examination. This was happening owing to the lack of labs in the country, but now some labs in India have initiated examination of NIPT tests within the country. Improvements in healthcare facilities in the country are likely to drive the market over the forecast period. In March 2021, Bio serve Biotechnology launched NIPT services in the country. Under the PRENITA brand, the company provides diagnostic testing for prenatal and postnatal patients, advanced preimplantation genetic screening/diagnosis, and carrier screening services.

Reasons to subscribe to India non invasive prenatal testing market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India non invasive prenatal testing market databook

Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into India non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.